Since the early stages of the COVID-19 vaccine rollout in the U.S., vaccine skeptics have used outdated interviews to spread claims that executives are refusing shots developed by their own ...
BERLIN, July 3 (Reuters) - BioNTech (22UAy.DE), opens new tab has held confidential talks with potential buyers ‌about German sites that the COVID‑19 vaccine maker plans to close, the Handelsblatt ...
BioNTech has not performed well in recent years, as its COVID-19 portfolio has struggled. However, the company's mRNA platform is looking increasingly valuable. Clinical and regulatory wins over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results